المؤلفون: Yuanmei Bai, Haimei Wu, Lijie Zheng, Yuhuan Xie, Feifan Liu, Yan Wan, Qiongchao Li, Peixin Guo

المصدر: Frontiers in Pharmacology, Vol 14 (2023)

مصطلحات موضوعية: Yajieshaba, liver fibrosis, Keap1-Nrf2 oxidative stress pathway, pharmacodynamics, mechanism, Therapeutics. Pharmacology, RM1-950

وصف الملف: electronic resource

Relation: https://www.frontiersin.org/articles/10.3389/fphar.2023.1124015/full; https://doaj.org/toc/1663-9812

URL الوصول: https://doaj.org/article/448966cebfc448c794429e7583bc3a85

المؤلفون: Yuanmei Bai, Haimei Wu, Lijie Zheng, Yuhuan Xie, Feifan Liu, Yan Wan, Qiongchao Li, Peixin Guo

مصطلحات موضوعية: Pharmacology, Basic Pharmacology, Clinical Pharmacology and Therapeutics, Clinical Pharmacy and Pharmacy Practice, Pharmaceutical Sciences, Pharmacogenomics, Toxicology (incl. Clinical Toxicology), Pharmacology and Pharmaceutical Sciences not elsewhere classified, Yajieshaba, liver fibrosis, Keap1-Nrf2 oxidative stress pathway, pharmacodynamics, mechanism

Relation: https://figshare.com/articles/dataset/DataSheet1_Mechanisms_of_Yajieshaba_in_the_treatment_of_liver_fibrosis_through_the_Keap1-Nrf2_signaling_pathway_PDF/22784324

الاتاحة: https://doi.org/10.3389/fphar.2023.1124015.s001
https://figshare.com/articles/dataset/DataSheet1_Mechanisms_of_Yajieshaba_in_the_treatment_of_liver_fibrosis_through_the_Keap1-Nrf2_signaling_pathway_PDF/22784324